• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产KPC的异质性耐药肺炎克雷伯菌中高水平碳青霉烯类耐药性的快速诱导

Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.

作者信息

Adams-Sapper Sheila, Nolen Shantell, Donzelli Grace Fox, Lal Mallika, Chen Kunihiko, Justo da Silva Livia Helena, Moreira Beatriz M, Riley Lee W

机构信息

School of Public Health, Division of Infectious Diseases and Vaccinology, University of California, Berkeley, Berkeley, California, USA.

Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

Antimicrob Agents Chemother. 2015;59(6):3281-9. doi: 10.1128/AAC.05100-14. Epub 2015 Mar 23.

DOI:10.1128/AAC.05100-14
PMID:25801565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4432212/
Abstract

Enterobacteriaceae strains producing the Klebsiella pneumoniae carbapenemase (KPC) have disseminated worldwide, causing an urgent threat to public health. KPC-producing strains often exhibit low-level carbapenem resistance, which may be missed by automated clinical detection systems. In this study, eight Klebsiella pneumoniae strains with heterogeneous resistance to imipenem were used to elucidate the factors leading from imipenem susceptibility to high-level resistance as defined by clinical laboratory testing standards. Time-kill analysis with an inoculum as low as 3 × 10(6) CFU/ml and concentrations of imipenem 8- and 16-fold higher than the MIC resulted in the initial killing of 99.9% of the population. However, full recovery of the population occurred by 20 h of incubation in the same drug concentrations. Population profiles showed that recovery was mediated by a heteroresistant subpopulation at a frequency of 2 × 10(-7) to 3 × 10(-6). Samples selected 2 h after exposure to imipenem were as susceptible as the unexposed parental strain and produced the major outer membrane porin OmpK36. However, between 4 to 8 h after exposure, OmpK36 became absent, and the imipenem MIC increased at least 32-fold. Individual colonies isolated from cultures after 20 h of exposure revealed both susceptible and resistant subpopulations. Once induced, however, the high-level imipenem resistance was maintained, and OmpK36 remained unexpressed even without continued carbapenem exposure. This study demonstrates the essential coordination between blaKPC and ompK36 expression mediating high-level imipenem resistance from a population of bacteria that initially exhibits a carbapenem-susceptibility phenotype.

摘要

产肺炎克雷伯菌碳青霉烯酶(KPC)的肠杆菌科菌株已在全球范围内传播,对公众健康构成了紧迫威胁。产KPC菌株通常表现出低水平的碳青霉烯耐药性,这可能会被自动化临床检测系统漏检。在本研究中,使用了8株对亚胺培南具有异质性耐药的肺炎克雷伯菌菌株,以阐明根据临床实验室检测标准,导致从亚胺培南敏感转变为高水平耐药的因素。用低至3×10⁶CFU/ml的接种量以及比最低抑菌浓度(MIC)高8倍和16倍的亚胺培南浓度进行时间杀菌分析,结果导致最初99.9%的菌被杀灭。然而,在相同药物浓度下孵育20小时后,菌量完全恢复。群体分析表明,恢复是由频率为2×10⁻⁷至3×10⁻⁶的异质性耐药亚群介导的。暴露于亚胺培南2小时后选取的样本与未暴露的亲本菌株一样敏感,并产生主要的外膜孔蛋白OmpK36。然而,在暴露后4至8小时之间,OmpK36消失,亚胺培南的MIC至少增加32倍。从暴露20小时后的培养物中分离出的单个菌落显示出敏感和耐药亚群。然而,一旦诱导产生,高水平的亚胺培南耐药性得以维持,即使没有持续的碳青霉烯暴露,OmpK36也仍然不表达。本研究证明了blaKPC与ompK36表达之间的基本协同作用,介导了从最初表现出碳青霉烯敏感表型的细菌群体中产生高水平的亚胺培南耐药性。

相似文献

1
Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.产KPC的异质性耐药肺炎克雷伯菌中高水平碳青霉烯类耐药性的快速诱导
Antimicrob Agents Chemother. 2015;59(6):3281-9. doi: 10.1128/AAC.05100-14. Epub 2015 Mar 23.
2
The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.外排泵抑制剂苯丙氨酸-精氨酸β-萘基酰胺(PAβN)增加了智利产 KPC 肺炎克雷伯菌临床分离株对碳青霉烯类药物的耐药性。
J Glob Antimicrob Resist. 2018 Mar;12:73-76. doi: 10.1016/j.jgar.2017.12.003. Epub 2017 Dec 21.
3
Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae.与产 KPC 肺炎克雷伯菌碳青霉烯类耐药升高相关的遗传因素。
Antimicrob Agents Chemother. 2010 Oct;54(10):4201-7. doi: 10.1128/AAC.00008-10. Epub 2010 Jul 26.
4
Role of association of OmpK35 and OmpK36 alteration and bla and/or bla genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae.OmpK35 和 OmpK36 改变与 bla 和/或 bla 基因的关联在非碳青霉烯酶产生肺炎克雷伯菌中赋予碳青霉烯类耐药的作用。
Int J Antimicrob Agents. 2018 Dec;52(6):898-905. doi: 10.1016/j.ijantimicag.2018.03.020. Epub 2018 Apr 2.
5
Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.纽约一家医疗中心爆发产新型碳青霉烯水解酶A类β-内酰胺酶KPC-3的肺炎克雷伯菌感染。
Antimicrob Agents Chemother. 2004 Dec;48(12):4793-9. doi: 10.1128/AAC.48.12.4793-4799.2004.
6
The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.高产碳青霉烯类耐药肺炎克雷伯菌的机制:产 IMP-1 型β-内酰胺酶的 OmpK36 缺陷株代表了日本高产碳青霉烯类耐药肺炎克雷伯菌的新威胁。
Microb Drug Resist. 2013 Aug;19(4):274-81. doi: 10.1089/mdr.2012.0248. Epub 2013 Mar 20.
7
Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.外膜孔蛋白K36对产KPC肺炎克雷伯菌碳青霉烯类药物敏感性的影响
J Med Microbiol. 2009 Oct;58(Pt 10):1303-1308. doi: 10.1099/jmm.0.012575-0. Epub 2009 Jun 25.
8
Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.携带blaVIM-1的肺炎克雷伯菌中碳青霉烯耐药水平多样性的来源
J Antimicrob Chemother. 2006 Sep;58(3):669-72. doi: 10.1093/jac/dkl302. Epub 2006 Jul 26.
9
Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain.质粒 pKpQIL 编码 KPC-3 和 TEM-1,赋予了一株具有极强耐药性的流行肺炎克雷伯菌对碳青霉烯类药物的耐药性。
J Antimicrob Chemother. 2010 Feb;65(2):243-8. doi: 10.1093/jac/dkp417. Epub 2009 Nov 24.
10
Effect of Porins and bla Expression on Activity of Imipenem with Relebactam in Klebsiella pneumoniae: Can Antibiotic Combinations Overcome Resistance?孔蛋白和bla表达对肺炎克雷伯菌中亚胺培南与瑞来巴坦联合活性的影响:抗生素组合能否克服耐药性?
Microb Drug Resist. 2018 Sep;24(7):877-881. doi: 10.1089/mdr.2018.0065. Epub 2018 May 21.

引用本文的文献

1
ESBL-Producing and Exhibit Divergent Paths During In-Human Evolution Towards Carbapenem Resistance.产超广谱β-内酰胺酶菌株在人体内向碳青霉烯类耐药进化过程中呈现出不同路径。
Microorganisms. 2025 Jun 14;13(6):1387. doi: 10.3390/microorganisms13061387.
2
Reporting antimicrobial susceptibility and detection of carbapenemase production in single and double carbapenemase-producing Gram-negative clinical isolates: a nationwide proficiency study.单产碳青霉烯酶和双产碳青霉烯酶革兰阴性临床分离株的抗菌药物敏感性报告及碳青霉烯酶产生情况检测:一项全国性能力验证研究
Front Microbiol. 2025 Jun 10;16:1605590. doi: 10.3389/fmicb.2025.1605590. eCollection 2025.
3
Emergence of population heterogeneity in Klebsiella pneumoniae with a bla-harboring plasmid: carbapenem resistance, virulence, and fitness.携带bla基因的肺炎克雷伯菌中群体异质性的出现:碳青霉烯类耐药性、毒力和适应性
J Biomed Sci. 2025 Feb 15;32(1):22. doi: 10.1186/s12929-024-01108-4.
4
Genetic Evaluation of Heteroresistance among Carbapenem-Susceptible Clinical Isolates of Enterobacterales.肠杆菌科碳青霉烯类敏感临床分离株中异质性耐药的基因评估
Can J Infect Dis Med Microbiol. 2024 Aug 26;2024:5014876. doi: 10.1155/2024/5014876. eCollection 2024.
5
Proteome analysis, genetic characterization, and antibiotic resistance patterns of Klebsiella pneumoniae clinical isolates.肺炎克雷伯菌临床分离株的蛋白质组分析、基因特征及抗生素耐药模式
AMB Express. 2024 May 9;14(1):54. doi: 10.1186/s13568-024-01710-7.
6
Detection and characterization of eravacycline heteroresistance in clinical bacterial isolates.临床细菌分离株中依拉环素异质性耐药的检测与特征分析
Front Microbiol. 2024 Mar 27;15:1332458. doi: 10.3389/fmicb.2024.1332458. eCollection 2024.
7
LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases.LL-37:结构、抗菌活性及其对淀粉样相关疾病的影响。
Biomolecules. 2024 Mar 8;14(3):320. doi: 10.3390/biom14030320.
8
Outer-Membrane Permeabilization, LPS Transport Inhibition: Activity, Interactions, and Structures of Thanatin Derived Antimicrobial Peptides.外膜通透性、LPS 转运抑制:Thanatin 衍生抗菌肽的活性、相互作用和结构。
Int J Mol Sci. 2024 Feb 9;25(4):2122. doi: 10.3390/ijms25042122.
9
Structures, Interactions and Activity of the N-Terminal Truncated Variants of Antimicrobial Peptide Thanatin.抗菌肽Thanatin的N端截短变体的结构、相互作用及活性
Antibiotics (Basel). 2024 Jan 12;13(1):74. doi: 10.3390/antibiotics13010074.
10
Ceftazidime-Avibactam Treatment for Bacteremia in Preterm Infants in NICU: A Clinical Experience.头孢他啶-阿维巴坦治疗新生儿重症监护病房早产儿菌血症的临床经验
Antibiotics (Basel). 2023 Jul 10;12(7):1169. doi: 10.3390/antibiotics12071169.

本文引用的文献

1
Single or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenems.肺炎克雷伯菌的单一或联合的抗菌药物耐药机制导致对不同碳青霉烯类药物的敏感性不同。
PLoS One. 2013 Nov 12;8(11):e79640. doi: 10.1371/journal.pone.0079640. eCollection 2013.
2
Whole-genome sequencing reveals a link between β-lactam resistance and synthetases of the alarmone (p)ppGpp in Staphylococcus aureus.全基因组测序揭示金黄色葡萄球菌中β-内酰胺类抗生素耐药性与应激感应核苷酸(p)ppGpp 合成酶之间的关系。
Microb Drug Resist. 2013 Jun;19(3):153-9. doi: 10.1089/mdr.2013.0053. Epub 2013 May 9.
3
The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.外排抑制剂苯丙氨酸-精氨酸 β-萘酰胺(PAβN)可通透革兰氏阴性菌的外膜。
PLoS One. 2013;8(3):e60666. doi: 10.1371/journal.pone.0060666. Epub 2013 Mar 27.
4
The multiple paths to heteroresistance and intermediate resistance to vancomycin in Staphylococcus aureus.金黄色葡萄球菌对万古霉素产生异质性耐药和中介耐药的多种途径。
J Infect Dis. 2013 Jul;208(1):7-9. doi: 10.1093/infdis/jit136. Epub 2013 Mar 28.
5
Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.治疗产碳青霉烯酶肺炎克雷伯菌(KPC)感染:已发表的病例系列和病例报告综述。
Ann Clin Microbiol Antimicrob. 2012 Dec 13;11:32. doi: 10.1186/1476-0711-11-32.
6
Role of ISKpn7 and deletions in blaKPC gene expression.ISKpn7 的作用和 blaKPC 基因表达中的缺失。
Antimicrob Agents Chemother. 2012 Sep;56(9):4753-9. doi: 10.1128/AAC.00334-12. Epub 2012 Jun 25.
7
Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniae.耐氯己定的肺炎克雷伯菌极度耐药株。
J Hosp Infect. 2012 May;81(1):15-9. doi: 10.1016/j.jhin.2012.02.007. Epub 2012 Mar 30.
8
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.鲍曼不动杆菌的黏菌素耐药性:临床报告、机制及抗菌策略
J Antimicrob Chemother. 2012 Jul;67(7):1607-15. doi: 10.1093/jac/dks084. Epub 2012 Mar 22.
9
Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.产 KPC 肺炎克雷伯菌血症的治疗转归:联合抗菌方案的优势。
Antimicrob Agents Chemother. 2012 Apr;56(4):2108-13. doi: 10.1128/AAC.06268-11. Epub 2012 Jan 17.
10
Klebsiella pneumoniae ST258 producing KPC-3 identified in italy carries novel plasmids and OmpK36/OmpK35 porin variants.在意大利发现的产 KPC-3 的肺炎克雷伯菌 ST258 携带新型质粒和 OmpK36/OmpK35 孔蛋白变体。
Antimicrob Agents Chemother. 2012 Apr;56(4):2143-5. doi: 10.1128/AAC.05308-11. Epub 2012 Jan 17.